Similar transcriptional stability, over seven generations, was seen in a xenograft lineage established by injection of CD133+ cells purified from the tumor of patient D55949 (Figure S4), which are enriched for tumor-initiating cells and depleted of stromal cells [1], [4]. The gene discussed is PROM1; the disease is neoplasm.